Exclusive

Publication

Byline

Location

US Patent Issued to UNIVERSITY OF NOTRE DAME DU LAC on Sept. 29 for "Dynamic-covalent hydrogels with glucose-specific and glucose-responsive diboronate crosslinking" (Indiana Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,277, issued on Sept. 29, was assigned to UNIVERSITY OF NOTRE DAME DU LAC (South Bend, Ind.). "Dynamic-covalent hydrogels with glucose-spec... Read More


US Patent Issued to THE REGENENTS OF THE UNIVERSITY OF CALIFORNIA on Sept. 29 for "Compositions and methods for wound healing" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,278, issued on Sept. 29, was assigned to THE REGENENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, Calif.). "Compositions and methods for wo... Read More


US Patent Issued to Baylor College of Medicine on Sept. 29 for "Chagas disease vaccine antigens with improved stability and decreased aggregation" (American, Mexican Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,280, issued on Sept. 29, was assigned to Baylor College of Medicine (Houston). "Chagas disease vaccine antigens with improved stability an... Read More


US Patent Issued to AMBIENT BIOSCIENCES on Sept. 29 for "Ambient temperature lipid particle storage systems and methods" (Michigan Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,281, issued on Sept. 29, was assigned to AMBIENT BIOSCIENCES INC. (Ann Arbor, Mich.). "Ambient temperature lipid particle storage systems ... Read More


US Patent Issued to Bavarian Nordic on Sept. 29 for "Recombinant modified vaccinia virus (MVA) vaccine against coronavirus disease" (German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,282, issued on Sept. 29, was assigned to Bavarian Nordic A/S (Hellerup, Denmark). "Recombinant modified vaccinia virus (MVA) vaccine again... Read More


US Patent Issued to Takeda Vaccines on Sept. 29 for "Dengue vaccine unit dose and administration thereof" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,283, issued on Sept. 29, was assigned to Takeda Vaccines Inc. (Cambridge, Mass.). "Dengue vaccine unit dose and administration thereof" wa... Read More


US Patent Issued to REPUBLIC OF KOREA (ANIMAL AND PLANT QUARANTINE AGENCY) on Sept. 29 for "Immune adjuvant and vaccine composition including the same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,284, issued on Sept. 29, was assigned to REPUBLIC OF KOREA (ANIMAL AND PLANT QUARANTINE AGENCY) (Gimcheon-si, South Korea). "Immune adjuva... Read More


US Patent Issued to MONASH UNIVERSITY, PETER MACCALLUM CANCER INSTITUTE on Sept. 29 for "Methods of activating cells via PTP 1B inhibition" (Australian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,285, issued on Sept. 29, was assigned to MONASH UNIVERSITY (Clayton, Australia) and PETER MACCALLUM CANCER INSTITUTE (Melbournd, Australia)... Read More


US Patent Issued to SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES on Sept. 29 for "Long-acting ropivacaine pharmaceutical composition, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,286, issued on Sept. 29, was assigned to SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (Shanghai). "Long-acting ropiva... Read More


US Patent Issued to UCB BIOSCIENCES on Sept. 29 for "Methods for increasing the bioavailability of nucleoside medicinal agents" (California Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,287, issued on Sept. 29, was assigned to UCB BIOSCIENCES INC. (Morrisville, N.C.). "Methods for increasing the bioavailability of nucleosi... Read More